  | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001  Peer Reviewed verified by ORBi |
 | GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc. Peer reviewed |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12. Peer Reviewed verified by ORBi |
 | GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc. Peer reviewed |
  | BAUDOUX, E., GIET, O., Jöris, M., Byam, C., Rocha, V., Ionescu, I., & Elmoazzen, H. (2016). Importing and Exporting Cord Blood Units. (Foundation for the Accreditation of Cellular Therapies). |
 | SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235. Peer Reviewed verified by ORBi |
 | LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y Peer Reviewed verified by ORBi |
 | Rouard, H., Boulanger, F., BAUDOUX, E., Calmels, B., de Vos, J., Gautier, E., Lacassagne, M. N., Tirefort, Y., Turlure, P., Chabannon, C., GERARD, C., GIET, O., Letellier, C., MONFORT, M., Thibert, J.-B., & Yakoub-Agha, I. (December 2015). Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC. Hématologie, 21 (Supp 3), 42-46. doi:10.1684/hma.2015.1070 Peer reviewed |
 | De Vos, J., Birebent, B., Faucher, C., GIET, O., Hicheri, Y., Lemarie, C., BAUDOUX, E., Garnier, F., Larghero, J., Pouthier, F., Thibert, J., & Yakoub-Agha, I. (2014). Contrôle de qualité des USP via segments attachés : recommandations de la SFGM-TC. Pathologie Biologie. doi:10.1016/j.patbio.2014.05.005 Peer Reviewed verified by ORBi |
 | Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279 Peer Reviewed verified by ORBi |
 | Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9 Peer Reviewed verified by ORBi |
 | MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068 Peer Reviewed verified by ORBi |
 | LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222 Peer Reviewed verified by ORBi |
 | Klykens, J., Pirnay, J., Verbeken, G., GIET, O., BAUDOUX, E., Jashari, R., Vanderkelen, A., & Ectors, N. (2013). Cleanrooms and tissue banking how happy I could be with either GMP or GTP? Cell and Tissue Banking. doi:10.1007/s10561-012-9355-8 Peer Reviewed verified by ORBi |
 | Foguenne, J., Di Stefano, Giet, O., Beguin, Y., & Gothot, A. (2009). Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica, 94, 185-194. doi:10.3324/haematol.13206 Peer Reviewed verified by ORBi |
 | Pirson, L.* , Baron, F.* , Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells, 24 (7), 1814-21. doi:10.1634/stemcells.2005-0290 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Pirson, L., Baron, F., Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2005). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDBeta2mNull [Poster presentation]. 20th general meeting of the Belgian Hematological Society, Brussels, Belgium. |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2004). The tyrosine kinase inhibitor Imatinib increases irradiation toxicity but does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 19th general meeting of the Belgian Hematological Society, Brussels, Belgium. |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 32nd annual meeting of the International Society of Experimental Hematology, Paris, France. |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 18th general meeting of the Belgian Hematological Society, Brussels, Belgium. |
 | Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2003). Binding and migration across fibronectin and VCAM-1 of cycling hematopoietic progenitor cells. Leukemia and Lymphoma, 44 (8), 1379-83. doi:10.1080/1042819031000083406 Peer Reviewed verified by ORBi |
 | Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2002). Modulation par le cycle cellulaire de l'implantation des cellules souches hématopoïétiques. Hématologie, 8, 397-404. Peer reviewed |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2002). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibior STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 44th annual meeting and exposition of American Society of Hematology, Philadelphia, United States. |
 | Giet, O., Van Bockstaele, D. R., Di Stefano, I., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2002). Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood, 99 (6), 2023-31. doi:10.1182/blood.V99.6.2023 Peer Reviewed verified by ORBi |
 | Huygen, S., Giet, O., Artisien, V., Di Stefano, I., Beguin, Y., & Gothot, A. (2002). Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture. Blood, 100 (8), 2744-52. doi:10.1182/blood.V100.8.2744 Peer Reviewed verified by ORBi |
 | Giet, O., Huygen, S., Beguin, Y., & Gothot, A. (2001). Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin. Experimental Hematology, 29 (4), 515-24. doi:10.1016/S0301-472X(00)00682-2 Peer reviewed |